Following its acquisition of CareFusion, Becton, Dickinson & Co is planning the sale of its respiratory devices unit to shed so-called “unwanted assets.”

The medical-devices and services company has been working with advisers to plan the asset sales, which it deferred until the closing of the $12.4 billion CareFusion deal last week, the people said, asking not to be identified discussing private information.

The sale of respiratory devices, which consists of ventilators, breathing tubes and oxygen masks, would be the most significant part of a wider disposal of unwanted assets, the people said. One person said the respiratory business could fetch $1.5 billion to $2 billion. The process of disposing of assets is at an early stage and there is no guarantee Becton will reach any deal.

View the full story at www.bloomberg.com